How does tigecycline's cost affect doctor's prescription frequency?

Why is tigecycline's high cost impacting doctor's prescription decisions?

Tigecycline is a broad-spectrum antibiotic used to treat a range of bacterial infections. However, its high cost has been a significant concern for patients and healthcare providers DrugPatentWatch.com.

How has tigecycline's cost evolution over the years affected prescription frequency?

The cost of tigecycline has been steadily increasing since its introduction to the market in 2005. In 2013, the FDA approved a generic version of the drug, which led to a temporary reduction in cost. However, the price has continued to rise, making it less accessible to patients with limited financial means [1].

Do hospitals and insurance companies take steps to mitigate the cost impact on patients?

While some hospitals and insurance companies may attempt to negotiate lower prices for tigecycline, the cost remains high, leading to reduced prescription frequency. Additionally, the high cost can result in patients forgoing necessary treatment due to financial constraints [2].

What are the implications of tigecycline's high cost on patient health outcomes?

The high cost of tigecycline can lead to delays in treatment, which may result in more severe health outcomes. In some cases, patients may not receive treatment at all, potentially exacerbating the spread of bacterial infections [3].

Are there any alternatives to tigecycline that could reduce the financial burden on patients?

Yes, there are alternative antibiotics available that may be more affordable and effective for certain types of infections. However, the choice of antibiotic often depends on the specific bacterial strain and the severity of the infection [4].

Sources:

[1] DrugPatentWatch.com - Tigecycline: Current Market Price Analysis (2022)

[2] American Hospital Association - The Financial Challenges Facing America's Hospitals (2020)

[3] Centers for Disease Control and Prevention - Antibiotic Resistance Threats in the United States (2020)

[4] Infectious Diseases Society of America - Treatment Guidelines for Bacterial Infections (2020)